ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 372950 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 372950; 2) Community: the network communities that were significantly associated with the response to NSC 372950; 3) Molecule: the relationships between components within communities and NSC 372950; 4) MDR: the compounds that were significantly associated with the NSC 372950.

NSC Compound Enrichment Correlation
NSC 688816 Null 0.036145517892443 -0.22306666
NSC 728323 16-[3-Methoxy-4-(2-pyrrolidine-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.036145517892443 0.49256836
NSC 113951 6-Bromotoyocamycin 0.0376362543535812 0.39908111
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.0376362543535812 0.68053974
NSC 135371 Null 0.0376362543535812 0.38387959
NSC 26273 6-Benzylthioinosine 0.0376362543535812 0.28718832
NSC 294526 Null 0.0376362543535812 0.28466913
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0376362543535812 0.35416528
NSC 373980 Null 0.0376362543535815 0.49418039
NSC 374028 Camptothecin Derivative 0.0376362543535815 0.30200677
Total:169  Current:132    [First] [Prev] [Next] [Last]